Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa (CogUK)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2013 by Imperial College London.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Cheif Investigator: Alan Winston
collaborators: Pfizer
Information provided by (Responsible Party):
Naomi Gardner, Imperial College London
ClinicalTrials.gov Identifier:
NCT01367236
First received: June 3, 2011
Last updated: April 3, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)